Get In Touch

Global Dry Eye Disease Market to Bag US$7.7 Bn with Launch of Advanced Diagnostic Tools

The global dry eye disease market is envisaged in a report by Transparency Market Research (TMR) to find an increase in the level of competition due to rising prevalence of the eye condition. Research and development of groundbreaking drugs could see a rise as several patents stand on the brink of expiration. As a result, enrolment in clinical trials is expected to surge in the coming years. With a view to strengthen their position in the market, companies could ink licensing agreements and forge tactical collaborations. In order to win over their rivalry with other players, they are anticipated to back their blockbuster drugs. Allergan plc, Santen Pharmaceutical Co., Ltd., and Novartis AG are some of the companies that could make their presence known in the market.

TMR envisions the global dry eye disease market to post a 4.5% CAGR during the forecast tenure 2017-2025 to be worth a US$7.7 bn by the end of 2025. In 2016, the market was valued at a US$5.0 bn. By product, the market is expected to witness anti-inflammatory drugs securing their lead in terms of revenue share. Regionally, taking into account its US$2.7 bn valuation in 2017, North America could take the driver’s seat of the market.

gobal dry eye disease market

Technical Advancements and Promising Pipeline Products Assure Improved Growth

Growing incidence of dry eye disease is foreseen to give a strong momentum to the global market. While this could be an obvious growth factor of the market, there are other factors that could further push growth in the near future. For instance, increasing healthcare expenditure and patient awareness are expected to emerge as promising growth factors of the market. Growth of the market could also increase due to the introduction of advanced medications and diagnostic equipment.

Over the years, treatment for dry eye disease has evolved drastically with the advent of techniques that are ahead of the times. This could be evidenced by the introduction of advanced hyaluronic acid-based lubricants and lipid emulsions replacing artificial tears that include isotonic sodium chloride.

Brands with Drug Patents Accused of Extortionately Pricing High Demand Products

Patent expiry is prognosticated to loom as a threat over market growth of players. On the other hand, exorbitant pricing may not be a good strategy to adopt for players who possess patents for their drugs. Moreover, the dearth of prescription drugs in the international dry eye disease market could hamper demand in the future years.

Nonetheless, the bandwagon of developing novel therapeutics for effective treatment of dry eye disease is prophesied to increase the popularity of the global market. Launch of new eye drops and swelling investment in drug-loaded punctal plugs and drug-eluting contact lenses could help with more opportunities in the market.

The information presented in this review is based on a TMR report, titled “Dry Eye Disease Market (Product - Artificial Tears, Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast), Punctal Plugs, and Secretagogue; Distribution Channel - Hospital Pharmacies, Independent Pharmacies and Drug Stores, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025.”

The global dry eye disease market has been segmented as presented below:

Global Dry Eye Disease Market by Product

  • Artificial Tears
  • Anti-inflammatory Drugs
    • Cyclosporine
    • Corticosteroids
    • Lifitegrast
  • Punctal Plugs
  • Secretagogue

Global Dry Eye Disease Market by Distribution Channel

  • Hospital Pharmacies
  • Independent Pharmacies and Drug Stores
  • Online Pharmacies

Global Dry Eye Disease Market by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia and New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • GCC Countries
    • South Africa
    • Israel
    • Rest of MEA

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

7 of 10 large enterprizes view our ToC to take the right decision.

View Report ToC